Z15.81

Clinical Causes: Inherited gene mutations, primarily in specific genes such as RET, MEN1, and CDKN1B. Family history of MEN or related endocrine tumors. Genetic mutations passed down from parents that increase tumor development risk.

Key Symptoms: Symptoms vary depending on the glands affected and tumor types but may include: - Neck swelling or lumps if the thyroid is involved. - Elevated blood calcium levels, leading to fatigue, weakness, or kidney stones, if parathyroid tumors are present. - Symptoms of hormone overproduction like rapid heartbeat, sweating, or weight loss, if adrenal tumors produce excess hormones. - Pancreatic symptoms such as abdominal pain, weight loss, or diabetes if pancreatic tumors develop. - Visual changes or other neurological symptoms if tumors grow near or press on nerves.

Diagnosis Path: Diagnosing genetic susceptibility to MEN typically involves a combination of genetic testing, family medical history review, and screening for tumors. Medical professionals may perform blood tests, imaging studies like MRI or ultrasound, and biopsy procedures to identify tumors or pre-tumorous changes. Genetic counseling is often recommended for individuals with a family history suggestive of MEN to assess their risk and discuss testing options.

Treatment Protocols: Regular screening and monitoring for tumor development in endocrine glands. Surgical removal of tumors or affected glands to prevent or treat complications. Medications to control hormone levels and mitigate symptoms. Targeted therapies or chemotherapy if malignant tumors are identified. Genetic counseling and familial testing to inform relatives of their risks and consider preventative measures.